Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled DevicesHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderActive, not recruitingPhase 42024-11-18NCT05626777

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
GlaxoSmithKline294
Hospices Civils de Lyon429

8 results · Page 1 of 1